ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell Regeneration Medicine Market Research Report 2025
Published Date: October 2025
|
Report Code: QYRE-Auto-36K11137
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell Regeneration Medicine Market Research Report 2022
BUY CHAPTERS

Global Cell Regeneration Medicine Market Research Report 2025

Code: QYRE-Auto-36K11137
Report
October 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
J &J (DePuy Synthes)
Medtronic Inc
Zimmer Biomet
Stryker
Allergan plc
MiMedx Group
Organogenesis Inc
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast Limited
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
NuVasive
Evergen
Japan Tissue Engineering

Cell Regeneration Medicine Market Size

The global market for Cell Regeneration Medicine was valued at US$ 23561 million in the year 2024 and is projected to reach a revised size of US$ 72163 million by 2031, growing at a CAGR of 17.7% during the forecast period.

Cell Regeneration Medicine Market

Cell Regeneration Medicine Market

The global cell regenerative medicine market is expected to reach $23.5 billion in 2024, with a gross profit margin of approximately 50-70%.
Cell regenerative medicine is a core area of ​​regenerative medicine, aiming to repair damaged tissues and organs and restore their function by activating, regulating, or supplementing cells with regenerative potential. This field integrates multidisciplinary technologies such as cell biology, materials science, and engineering, providing innovative solutions for treating degenerative diseases, wound repair, and anti-aging.
The upstream process involves cell preparation, comprising "chips + consumables + reagents." Equipment includes physical safety cabinets, isolators, closed automated bioreactors, programmed cooling units, and liquid nitrogen tanks. Consumables include cell culture bags, sterile pipettes/thermostats, and cryotubes. Reagents include serum-free culture media, cytokines, activating antibodies, and magnetic beads.
Future advancements in cell therapy will depend significantly on deep integration with other cutting-edge technologies.
Gene editing technology: Gene editing tools, such as CRISPR, are driving cell therapy from simple cell replacement to therapies capable of precisely repairing disease-causing genes. For example, the base editing therapy BEAM-101, which has received orphan drug designation, is designed to treat blood disorders such as beta-thalassemia by editing a specific gene to activate fetal hemoglobin. This represents a more precise and safer path to gene correction.
Artificial Intelligence and Automation: The complex, personalized manufacturing process for cell therapies is a key constraint to their accessibility. AI and automation technologies are addressing this bottleneck. For example, companies are collaborating to develop AI-driven automated cell therapy platforms to enable standardized, scalable production. Meanwhile, instrument-free, large-scale cell sorting technologies have emerged, significantly reducing time and costs.
Exploring New Cell Models: Beyond technology platforms, research into cells themselves is also deepening. For example, patient-derived organoids are being used for more precise drug screening, while microbubble-based cell sorting platforms are making production more efficient.
This report aims to provide a comprehensive presentation of the global market for Cell Regeneration Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Regeneration Medicine.
The Cell Regeneration Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Regeneration Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, by Cell Sources and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Regeneration Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell Regeneration Medicine Market Report

Report Metric Details
Report Name Cell Regeneration Medicine Market
Accounted market size in year US$ 23561 million
Forecasted market size in 2031 US$ 72163 million
CAGR 17.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Stem Cell Therapy
  • Tissue Engineering and 3D Bioprinting
  • Immune Cell Therapy
  • Gene-Edited Cell Therapy
Segment by Cell Sources
  • Autologous
  • Allogeneic
  • Xenogeneic
Segment by Cell Activity
  • Live Cell Therapy
  • Cell-Free Exosome/Secretome Therapy
Segment by Application
  • Dermatology
  • Musculoskeletal
  • Immunology and Inflammation
  • Oncology
  • Cardiovascular
  • Ophthalmology
  • Other Therapeutic Categories
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company J & J (DePuy Synthes), Medtronic, Zimmer Biomet, Stryker, Allergan, MiMedx Group, Organogenesis, Fujifilm Cellular Dynamics, Osiris Therapeutics, Vcanbio, CCBC, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, AMAG Pharmaceuticals (CBR), ViaCord, CordLife, Integra LifeSciences, Nuvasive, Evergen, Japan Tissue Engineering
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Cell Sources etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell Regeneration Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cell Regeneration Medicine Market growing?

Ans: The Cell Regeneration Medicine Market witnessing a CAGR of 17.7% during the forecast period 2025-2031.

What is the Cell Regeneration Medicine Market size in 2031?

Ans: The Cell Regeneration Medicine Market size in 2031 will be US$ 72163 million.

Who are the main players in the Cell Regeneration Medicine Market report?

Ans: The main players in the Cell Regeneration Medicine Market are J & J (DePuy Synthes), Medtronic, Zimmer Biomet, Stryker, Allergan, MiMedx Group, Organogenesis, Fujifilm Cellular Dynamics, Osiris Therapeutics, Vcanbio, CCBC, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, AMAG Pharmaceuticals (CBR), ViaCord, CordLife, Integra LifeSciences, Nuvasive, Evergen, Japan Tissue Engineering

What are the Application segmentation covered in the Cell Regeneration Medicine Market report?

Ans: The Applications covered in the Cell Regeneration Medicine Market report are Dermatology, Musculoskeletal, Immunology and Inflammation, Oncology, Cardiovascular, Ophthalmology, Other Therapeutic Categories

What are the Type segmentation covered in the Cell Regeneration Medicine Market report?

Ans: The Types covered in the Cell Regeneration Medicine Market report are Stem Cell Therapy, Tissue Engineering and 3D Bioprinting, Immune Cell Therapy, Gene-Edited Cell Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Regeneration Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cell Therapy
1.2.3 Tissue Engineering and 3D Bioprinting
1.2.4 Immune Cell Therapy
1.2.5 Gene-Edited Cell Therapy
1.3 Market by Cell Sources
1.3.1 Global Cell Regeneration Medicine Market Size Growth Rate by Cell Sources: 2020 VS 2024 VS 2031
1.3.2 Autologous
1.3.3 Allogeneic
1.3.4 Xenogeneic
1.4 Market by Cell Activity
1.4.1 Global Cell Regeneration Medicine Market Size Growth Rate by Cell Activity: 2020 VS 2024 VS 2031
1.4.2 Live Cell Therapy
1.4.3 Cell-Free Exosome/Secretome Therapy
1.5 Market by Application
1.5.1 Global Cell Regeneration Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Dermatology
1.5.3 Musculoskeletal
1.5.4 Immunology and Inflammation
1.5.5 Oncology
1.5.6 Cardiovascular
1.5.7 Ophthalmology
1.5.8 Other Therapeutic Categories
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Cell Regeneration Medicine Market Perspective (2020-2031)
2.2 Global Cell Regeneration Medicine Growth Trends by Region
2.2.1 Global Cell Regeneration Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell Regeneration Medicine Historic Market Size by Region (2020-2025)
2.2.3 Cell Regeneration Medicine Forecasted Market Size by Region (2026-2031)
2.3 Cell Regeneration Medicine Market Dynamics
2.3.1 Cell Regeneration Medicine Industry Trends
2.3.2 Cell Regeneration Medicine Market Drivers
2.3.3 Cell Regeneration Medicine Market Challenges
2.3.4 Cell Regeneration Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Regeneration Medicine Players by Revenue
3.1.1 Global Top Cell Regeneration Medicine Players by Revenue (2020-2025)
3.1.2 Global Cell Regeneration Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Top Cell Regeneration Medicine Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell Regeneration Medicine Revenue
3.4 Global Cell Regeneration Medicine Market Concentration Ratio
3.4.1 Global Cell Regeneration Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Regeneration Medicine Revenue in 2024
3.5 Global Key Players of Cell Regeneration Medicine Head office and Area Served
3.6 Global Key Players of Cell Regeneration Medicine, Product and Application
3.7 Global Key Players of Cell Regeneration Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Regeneration Medicine Breakdown Data by Type
4.1 Global Cell Regeneration Medicine Historic Market Size by Type (2020-2025)
4.2 Global Cell Regeneration Medicine Forecasted Market Size by Type (2026-2031)
5 Cell Regeneration Medicine Breakdown Data by Application
5.1 Global Cell Regeneration Medicine Historic Market Size by Application (2020-2025)
5.2 Global Cell Regeneration Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell Regeneration Medicine Market Size (2020-2031)
6.2 North America Cell Regeneration Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell Regeneration Medicine Market Size by Country (2020-2025)
6.4 North America Cell Regeneration Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Regeneration Medicine Market Size (2020-2031)
7.2 Europe Cell Regeneration Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell Regeneration Medicine Market Size by Country (2020-2025)
7.4 Europe Cell Regeneration Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cell Regeneration Medicine Market Size (2020-2031)
8.2 Asia-Pacific Cell Regeneration Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell Regeneration Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell Regeneration Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cell Regeneration Medicine Market Size (2020-2031)
9.2 Latin America Cell Regeneration Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell Regeneration Medicine Market Size by Country (2020-2025)
9.4 Latin America Cell Regeneration Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Regeneration Medicine Market Size (2020-2031)
10.2 Middle East & Africa Cell Regeneration Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell Regeneration Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell Regeneration Medicine Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 J & J (DePuy Synthes)
11.1.1 J & J (DePuy Synthes) Company Details
11.1.2 J & J (DePuy Synthes) Business Overview
11.1.3 J & J (DePuy Synthes) Cell Regeneration Medicine Introduction
11.1.4 J & J (DePuy Synthes) Revenue in Cell Regeneration Medicine Business (2020-2025)
11.1.5 J & J (DePuy Synthes) Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Cell Regeneration Medicine Introduction
11.2.4 Medtronic Revenue in Cell Regeneration Medicine Business (2020-2025)
11.2.5 Medtronic Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Cell Regeneration Medicine Introduction
11.3.4 Zimmer Biomet Revenue in Cell Regeneration Medicine Business (2020-2025)
11.3.5 Zimmer Biomet Recent Development
11.4 Stryker
11.4.1 Stryker Company Details
11.4.2 Stryker Business Overview
11.4.3 Stryker Cell Regeneration Medicine Introduction
11.4.4 Stryker Revenue in Cell Regeneration Medicine Business (2020-2025)
11.4.5 Stryker Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Cell Regeneration Medicine Introduction
11.5.4 Allergan Revenue in Cell Regeneration Medicine Business (2020-2025)
11.5.5 Allergan Recent Development
11.6 MiMedx Group
11.6.1 MiMedx Group Company Details
11.6.2 MiMedx Group Business Overview
11.6.3 MiMedx Group Cell Regeneration Medicine Introduction
11.6.4 MiMedx Group Revenue in Cell Regeneration Medicine Business (2020-2025)
11.6.5 MiMedx Group Recent Development
11.7 Organogenesis
11.7.1 Organogenesis Company Details
11.7.2 Organogenesis Business Overview
11.7.3 Organogenesis Cell Regeneration Medicine Introduction
11.7.4 Organogenesis Revenue in Cell Regeneration Medicine Business (2020-2025)
11.7.5 Organogenesis Recent Development
11.8 Fujifilm Cellular Dynamics
11.8.1 Fujifilm Cellular Dynamics Company Details
11.8.2 Fujifilm Cellular Dynamics Business Overview
11.8.3 Fujifilm Cellular Dynamics Cell Regeneration Medicine Introduction
11.8.4 Fujifilm Cellular Dynamics Revenue in Cell Regeneration Medicine Business (2020-2025)
11.8.5 Fujifilm Cellular Dynamics Recent Development
11.9 Osiris Therapeutics
11.9.1 Osiris Therapeutics Company Details
11.9.2 Osiris Therapeutics Business Overview
11.9.3 Osiris Therapeutics Cell Regeneration Medicine Introduction
11.9.4 Osiris Therapeutics Revenue in Cell Regeneration Medicine Business (2020-2025)
11.9.5 Osiris Therapeutics Recent Development
11.10 Vcanbio
11.10.1 Vcanbio Company Details
11.10.2 Vcanbio Business Overview
11.10.3 Vcanbio Cell Regeneration Medicine Introduction
11.10.4 Vcanbio Revenue in Cell Regeneration Medicine Business (2020-2025)
11.10.5 Vcanbio Recent Development
11.11 CCBC
11.11.1 CCBC Company Details
11.11.2 CCBC Business Overview
11.11.3 CCBC Cell Regeneration Medicine Introduction
11.11.4 CCBC Revenue in Cell Regeneration Medicine Business (2020-2025)
11.11.5 CCBC Recent Development
11.12 Cytori
11.12.1 Cytori Company Details
11.12.2 Cytori Business Overview
11.12.3 Cytori Cell Regeneration Medicine Introduction
11.12.4 Cytori Revenue in Cell Regeneration Medicine Business (2020-2025)
11.12.5 Cytori Recent Development
11.13 Celgene
11.13.1 Celgene Company Details
11.13.2 Celgene Business Overview
11.13.3 Celgene Cell Regeneration Medicine Introduction
11.13.4 Celgene Revenue in Cell Regeneration Medicine Business (2020-2025)
11.13.5 Celgene Recent Development
11.14 Vericel Corporation
11.14.1 Vericel Corporation Company Details
11.14.2 Vericel Corporation Business Overview
11.14.3 Vericel Corporation Cell Regeneration Medicine Introduction
11.14.4 Vericel Corporation Revenue in Cell Regeneration Medicine Business (2020-2025)
11.14.5 Vericel Corporation Recent Development
11.15 Guanhao Biotech
11.15.1 Guanhao Biotech Company Details
11.15.2 Guanhao Biotech Business Overview
11.15.3 Guanhao Biotech Cell Regeneration Medicine Introduction
11.15.4 Guanhao Biotech Revenue in Cell Regeneration Medicine Business (2020-2025)
11.15.5 Guanhao Biotech Recent Development
11.16 Mesoblast
11.16.1 Mesoblast Company Details
11.16.2 Mesoblast Business Overview
11.16.3 Mesoblast Cell Regeneration Medicine Introduction
11.16.4 Mesoblast Revenue in Cell Regeneration Medicine Business (2020-2025)
11.16.5 Mesoblast Recent Development
11.17 AMAG Pharmaceuticals (CBR)
11.17.1 AMAG Pharmaceuticals (CBR) Company Details
11.17.2 AMAG Pharmaceuticals (CBR) Business Overview
11.17.3 AMAG Pharmaceuticals (CBR) Cell Regeneration Medicine Introduction
11.17.4 AMAG Pharmaceuticals (CBR) Revenue in Cell Regeneration Medicine Business (2020-2025)
11.17.5 AMAG Pharmaceuticals (CBR) Recent Development
11.18 ViaCord
11.18.1 ViaCord Company Details
11.18.2 ViaCord Business Overview
11.18.3 ViaCord Cell Regeneration Medicine Introduction
11.18.4 ViaCord Revenue in Cell Regeneration Medicine Business (2020-2025)
11.18.5 ViaCord Recent Development
11.19 CordLife
11.19.1 CordLife Company Details
11.19.2 CordLife Business Overview
11.19.3 CordLife Cell Regeneration Medicine Introduction
11.19.4 CordLife Revenue in Cell Regeneration Medicine Business (2020-2025)
11.19.5 CordLife Recent Development
11.20 Integra LifeSciences
11.20.1 Integra LifeSciences Company Details
11.20.2 Integra LifeSciences Business Overview
11.20.3 Integra LifeSciences Cell Regeneration Medicine Introduction
11.20.4 Integra LifeSciences Revenue in Cell Regeneration Medicine Business (2020-2025)
11.20.5 Integra LifeSciences Recent Development
11.21 Nuvasive
11.21.1 Nuvasive Company Details
11.21.2 Nuvasive Business Overview
11.21.3 Nuvasive Cell Regeneration Medicine Introduction
11.21.4 Nuvasive Revenue in Cell Regeneration Medicine Business (2020-2025)
11.21.5 Nuvasive Recent Development
11.22 Evergen
11.22.1 Evergen Company Details
11.22.2 Evergen Business Overview
11.22.3 Evergen Cell Regeneration Medicine Introduction
11.22.4 Evergen Revenue in Cell Regeneration Medicine Business (2020-2025)
11.22.5 Evergen Recent Development
11.23 Japan Tissue Engineering
11.23.1 Japan Tissue Engineering Company Details
11.23.2 Japan Tissue Engineering Business Overview
11.23.3 Japan Tissue Engineering Cell Regeneration Medicine Introduction
11.23.4 Japan Tissue Engineering Revenue in Cell Regeneration Medicine Business (2020-2025)
11.23.5 Japan Tissue Engineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
J &J (DePuy Synthes)
Medtronic Inc
Zimmer Biomet
Stryker
Allergan plc
MiMedx Group
Organogenesis Inc
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast Limited
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
NuVasive
Evergen
Japan Tissue Engineering
List of Tables
 Table 1. Global Cell Regeneration Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Stem Cell Therapy
 Table 3. Key Players of Tissue Engineering and 3D Bioprinting
 Table 4. Key Players of Immune Cell Therapy
 Table 5. Key Players of Gene-Edited Cell Therapy
 Table 6. Global Cell Regeneration Medicine Market Size Growth Rate by Cell Sources (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Key Players of Autologous
 Table 8. Key Players of Allogeneic
 Table 9. Key Players of Xenogeneic
 Table 10. Global Cell Regeneration Medicine Market Size Growth Rate by Cell Activity (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Key Players of Live Cell Therapy
 Table 12. Key Players of Cell-Free Exosome/Secretome Therapy
 Table 13. Global Cell Regeneration Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 14. Global Cell Regeneration Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 15. Global Cell Regeneration Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 16. Global Cell Regeneration Medicine Market Share by Region (2020-2025)
 Table 17. Global Cell Regeneration Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 18. Global Cell Regeneration Medicine Market Share by Region (2026-2031)
 Table 19. Cell Regeneration Medicine Market Trends
 Table 20. Cell Regeneration Medicine Market Drivers
 Table 21. Cell Regeneration Medicine Market Challenges
 Table 22. Cell Regeneration Medicine Market Restraints
 Table 23. Global Cell Regeneration Medicine Revenue by Players (2020-2025) & (US$ Million)
 Table 24. Global Cell Regeneration Medicine Market Share by Players (2020-2025)
 Table 25. Global Top Cell Regeneration Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Regeneration Medicine as of 2024)
 Table 26. Ranking of Global Top Cell Regeneration Medicine Companies by Revenue (US$ Million) in 2024
 Table 27. Global 5 Largest Players Market Share by Cell Regeneration Medicine Revenue (CR5 and HHI) & (2020-2025)
 Table 28. Global Key Players of Cell Regeneration Medicine, Headquarters and Area Served
 Table 29. Global Key Players of Cell Regeneration Medicine, Product and Application
 Table 30. Global Key Players of Cell Regeneration Medicine, Date of Enter into This Industry
 Table 31. Mergers & Acquisitions, Expansion Plans
 Table 32. Global Cell Regeneration Medicine Market Size by Type (2020-2025) & (US$ Million)
 Table 33. Global Cell Regeneration Medicine Revenue Market Share by Type (2020-2025)
 Table 34. Global Cell Regeneration Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 35. Global Cell Regeneration Medicine Revenue Market Share by Type (2026-2031)
 Table 36. Global Cell Regeneration Medicine Market Size by Application (2020-2025) & (US$ Million)
 Table 37. Global Cell Regeneration Medicine Revenue Market Share by Application (2020-2025)
 Table 38. Global Cell Regeneration Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 39. Global Cell Regeneration Medicine Revenue Market Share by Application (2026-2031)
 Table 40. North America Cell Regeneration Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. North America Cell Regeneration Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 42. North America Cell Regeneration Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Europe Cell Regeneration Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Europe Cell Regeneration Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Europe Cell Regeneration Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Asia-Pacific Cell Regeneration Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Asia-Pacific Cell Regeneration Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 48. Asia-Pacific Cell Regeneration Medicine Market Size by Region (2026-2031) & (US$ Million)
 Table 49. Latin America Cell Regeneration Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 50. Latin America Cell Regeneration Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 51. Latin America Cell Regeneration Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 52. Middle East & Africa Cell Regeneration Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Middle East & Africa Cell Regeneration Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 54. Middle East & Africa Cell Regeneration Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 55. J & J (DePuy Synthes) Company Details
 Table 56. J & J (DePuy Synthes) Business Overview
 Table 57. J & J (DePuy Synthes) Cell Regeneration Medicine Product
 Table 58. J & J (DePuy Synthes) Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 59. J & J (DePuy Synthes) Recent Development
 Table 60. Medtronic Company Details
 Table 61. Medtronic Business Overview
 Table 62. Medtronic Cell Regeneration Medicine Product
 Table 63. Medtronic Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 64. Medtronic Recent Development
 Table 65. Zimmer Biomet Company Details
 Table 66. Zimmer Biomet Business Overview
 Table 67. Zimmer Biomet Cell Regeneration Medicine Product
 Table 68. Zimmer Biomet Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 69. Zimmer Biomet Recent Development
 Table 70. Stryker Company Details
 Table 71. Stryker Business Overview
 Table 72. Stryker Cell Regeneration Medicine Product
 Table 73. Stryker Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 74. Stryker Recent Development
 Table 75. Allergan Company Details
 Table 76. Allergan Business Overview
 Table 77. Allergan Cell Regeneration Medicine Product
 Table 78. Allergan Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 79. Allergan Recent Development
 Table 80. MiMedx Group Company Details
 Table 81. MiMedx Group Business Overview
 Table 82. MiMedx Group Cell Regeneration Medicine Product
 Table 83. MiMedx Group Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 84. MiMedx Group Recent Development
 Table 85. Organogenesis Company Details
 Table 86. Organogenesis Business Overview
 Table 87. Organogenesis Cell Regeneration Medicine Product
 Table 88. Organogenesis Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 89. Organogenesis Recent Development
 Table 90. Fujifilm Cellular Dynamics Company Details
 Table 91. Fujifilm Cellular Dynamics Business Overview
 Table 92. Fujifilm Cellular Dynamics Cell Regeneration Medicine Product
 Table 93. Fujifilm Cellular Dynamics Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 94. Fujifilm Cellular Dynamics Recent Development
 Table 95. Osiris Therapeutics Company Details
 Table 96. Osiris Therapeutics Business Overview
 Table 97. Osiris Therapeutics Cell Regeneration Medicine Product
 Table 98. Osiris Therapeutics Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 99. Osiris Therapeutics Recent Development
 Table 100. Vcanbio Company Details
 Table 101. Vcanbio Business Overview
 Table 102. Vcanbio Cell Regeneration Medicine Product
 Table 103. Vcanbio Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 104. Vcanbio Recent Development
 Table 105. CCBC Company Details
 Table 106. CCBC Business Overview
 Table 107. CCBC Cell Regeneration Medicine Product
 Table 108. CCBC Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 109. CCBC Recent Development
 Table 110. Cytori Company Details
 Table 111. Cytori Business Overview
 Table 112. Cytori Cell Regeneration Medicine Product
 Table 113. Cytori Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 114. Cytori Recent Development
 Table 115. Celgene Company Details
 Table 116. Celgene Business Overview
 Table 117. Celgene Cell Regeneration Medicine Product
 Table 118. Celgene Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 119. Celgene Recent Development
 Table 120. Vericel Corporation Company Details
 Table 121. Vericel Corporation Business Overview
 Table 122. Vericel Corporation Cell Regeneration Medicine Product
 Table 123. Vericel Corporation Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 124. Vericel Corporation Recent Development
 Table 125. Guanhao Biotech Company Details
 Table 126. Guanhao Biotech Business Overview
 Table 127. Guanhao Biotech Cell Regeneration Medicine Product
 Table 128. Guanhao Biotech Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 129. Guanhao Biotech Recent Development
 Table 130. Mesoblast Company Details
 Table 131. Mesoblast Business Overview
 Table 132. Mesoblast Cell Regeneration Medicine Product
 Table 133. Mesoblast Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 134. Mesoblast Recent Development
 Table 135. AMAG Pharmaceuticals (CBR) Company Details
 Table 136. AMAG Pharmaceuticals (CBR) Business Overview
 Table 137. AMAG Pharmaceuticals (CBR) Cell Regeneration Medicine Product
 Table 138. AMAG Pharmaceuticals (CBR) Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 139. AMAG Pharmaceuticals (CBR) Recent Development
 Table 140. ViaCord Company Details
 Table 141. ViaCord Business Overview
 Table 142. ViaCord Cell Regeneration Medicine Product
 Table 143. ViaCord Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 144. ViaCord Recent Development
 Table 145. CordLife Company Details
 Table 146. CordLife Business Overview
 Table 147. CordLife Cell Regeneration Medicine Product
 Table 148. CordLife Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 149. CordLife Recent Development
 Table 150. Integra LifeSciences Company Details
 Table 151. Integra LifeSciences Business Overview
 Table 152. Integra LifeSciences Cell Regeneration Medicine Product
 Table 153. Integra LifeSciences Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 154. Integra LifeSciences Recent Development
 Table 155. Nuvasive Company Details
 Table 156. Nuvasive Business Overview
 Table 157. Nuvasive Cell Regeneration Medicine Product
 Table 158. Nuvasive Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 159. Nuvasive Recent Development
 Table 160. Evergen Company Details
 Table 161. Evergen Business Overview
 Table 162. Evergen Cell Regeneration Medicine Product
 Table 163. Evergen Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 164. Evergen Recent Development
 Table 165. Japan Tissue Engineering Company Details
 Table 166. Japan Tissue Engineering Business Overview
 Table 167. Japan Tissue Engineering Cell Regeneration Medicine Product
 Table 168. Japan Tissue Engineering Revenue in Cell Regeneration Medicine Business (2020-2025) & (US$ Million)
 Table 169. Japan Tissue Engineering Recent Development
 Table 170. Research Programs/Design for This Report
 Table 171. Key Data Information from Secondary Sources
 Table 172. Key Data Information from Primary Sources
 Table 173. Authors List of This Report


List of Figures
 Figure 1. Cell Regeneration Medicine Picture
 Figure 2. Global Cell Regeneration Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell Regeneration Medicine Market Share by Type: 2024 VS 2031
 Figure 4. Stem Cell Therapy Features
 Figure 5. Tissue Engineering and 3D Bioprinting Features
 Figure 6. Immune Cell Therapy Features
 Figure 7. Gene-Edited Cell Therapy Features
 Figure 8. Global Cell Regeneration Medicine Market Size Comparison by Cell Sources (2020-2031) & (US$ Million)
 Figure 9. Autologous Features
 Figure 10. Allogeneic Features
 Figure 11. Xenogeneic Features
 Figure 12. Global Cell Regeneration Medicine Market Size Comparison by Cell Activity (2020-2031) & (US$ Million)
 Figure 13. Live Cell Therapy Features
 Figure 14. Cell-Free Exosome/Secretome Therapy Features
 Figure 15. Global Cell Regeneration Medicine Market Size by Application (2020-2031) & (US$ Million)
 Figure 16. Global Cell Regeneration Medicine Market Share by Application: 2024 VS 2031
 Figure 17. Dermatology Case Studies
 Figure 18. Musculoskeletal Case Studies
 Figure 19. Immunology and Inflammation Case Studies
 Figure 20. Oncology Case Studies
 Figure 21. Cardiovascular Case Studies
 Figure 22. Ophthalmology Case Studies
 Figure 23. Other Therapeutic Categories Case Studies
 Figure 24. Cell Regeneration Medicine Report Years Considered
 Figure 25. Global Cell Regeneration Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 26. Global Cell Regeneration Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 27. Global Cell Regeneration Medicine Market Share by Region: 2024 VS 2031
 Figure 28. Global Cell Regeneration Medicine Market Share by Players in 2024
 Figure 29. Global Cell Regeneration Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 30. The Top 10 and 5 Players Market Share by Cell Regeneration Medicine Revenue in 2024
 Figure 31. North America Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. North America Cell Regeneration Medicine Market Share by Country (2020-2031)
 Figure 33. United States Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Canada Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Europe Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Europe Cell Regeneration Medicine Market Share by Country (2020-2031)
 Figure 37. Germany Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. France Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. U.K. Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Italy Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Russia Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Ireland Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Asia-Pacific Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Asia-Pacific Cell Regeneration Medicine Market Share by Region (2020-2031)
 Figure 45. China Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Japan Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. South Korea Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Southeast Asia Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. India Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Australia & New Zealand Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Latin America Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Latin America Cell Regeneration Medicine Market Share by Country (2020-2031)
 Figure 53. Mexico Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Brazil Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. Middle East & Africa Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 56. Middle East & Africa Cell Regeneration Medicine Market Share by Country (2020-2031)
 Figure 57. Israel Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 59. UAE Cell Regeneration Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 60. J & J (DePuy Synthes) Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 61. Medtronic Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 62. Zimmer Biomet Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 63. Stryker Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 64. Allergan Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 65. MiMedx Group Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 66. Organogenesis Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 67. Fujifilm Cellular Dynamics Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 68. Osiris Therapeutics Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 69. Vcanbio Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 70. CCBC Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 71. Cytori Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 72. Celgene Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 73. Vericel Corporation Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 74. Guanhao Biotech Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 75. Mesoblast Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 76. AMAG Pharmaceuticals (CBR) Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 77. ViaCord Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 78. CordLife Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 79. Integra LifeSciences Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 80. Nuvasive Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 81. Evergen Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 82. Japan Tissue Engineering Revenue Growth Rate in Cell Regeneration Medicine Business (2020-2025)
 Figure 83. Bottom-up and Top-down Approaches for This Report
 Figure 84. Data Triangulation
 Figure 85. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Regenerative Medicine Products Market Research Report 2025
Global Translational Regenerative Medicine Market Insights Forecast to 2030
Platelet Regeneration in Vitro Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Orthopedic Regenerative Medicine Market Research Report 2025
Global Cell Therapy Regenerative Medicine Market Research Report 2025
Global Regenerative Medicine for Cartilage Market Size Status and Forecast 2021 2027
Orthopedic Regenerative Surgical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Based Regenerative Therapy Market Research Report 2024
Global Potential Therapy Equipment Market Insights Forecast to 2030
Serum free Cell Culture Media Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Healthcare and Rehabilitation Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global 0 Market Research Report 2024
Global 0 Market Research Report 2024
Global Tissue Engineering and Regeneration Market Research Report 2025
Global Healthcare Data Monetization Market Research Report 2025
Global Skin Rejuvenation and Resurfacing System Market Research Report 2025
Global Cell Therapy Manufacturing Market Research Report 2025
Cell Expansion Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
0 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neuronal Regeneration Stem Cell Therapy Market Research Report 2024

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions